1.17
|
7.34e-76
|
GO:0009987
|
cellular process
|
1.27
|
5.76e-56
|
GO:0044237
|
cellular metabolic process
|
1.25
|
1.62e-51
|
GO:0044238
|
primary metabolic process
|
1.33
|
1.91e-51
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.23
|
1.42e-50
|
GO:0008152
|
metabolic process
|
1.29
|
5.40e-48
|
GO:0043170
|
macromolecule metabolic process
|
1.20
|
8.77e-45
|
GO:0065007
|
biological regulation
|
1.21
|
9.60e-43
|
GO:0050789
|
regulation of biological process
|
1.21
|
4.57e-40
|
GO:0050794
|
regulation of cellular process
|
1.29
|
5.28e-33
|
GO:0019222
|
regulation of metabolic process
|
1.35
|
3.20e-32
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.32
|
9.09e-32
|
GO:0006807
|
nitrogen compound metabolic process
|
1.31
|
2.02e-31
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.32
|
1.18e-30
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.29
|
4.11e-30
|
GO:0031323
|
regulation of cellular metabolic process
|
1.29
|
5.81e-30
|
GO:0080090
|
regulation of primary metabolic process
|
1.30
|
1.11e-29
|
GO:0016043
|
cellular component organization
|
1.29
|
1.23e-27
|
GO:0071840
|
cellular component organization or biogenesis
|
1.41
|
2.36e-26
|
GO:0006464
|
protein modification process
|
1.33
|
3.14e-26
|
GO:0048518
|
positive regulation of biological process
|
1.37
|
2.55e-25
|
GO:0048523
|
negative regulation of cellular process
|
1.39
|
3.91e-25
|
GO:0043412
|
macromolecule modification
|
1.34
|
6.84e-25
|
GO:0048522
|
positive regulation of cellular process
|
1.36
|
1.63e-24
|
GO:0090304
|
nucleic acid metabolic process
|
1.34
|
2.24e-24
|
GO:0048519
|
negative regulation of biological process
|
1.32
|
1.34e-23
|
GO:0010468
|
regulation of gene expression
|
1.31
|
4.67e-23
|
GO:0071842
|
cellular component organization at cellular level
|
1.30
|
1.01e-21
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.55
|
7.01e-21
|
GO:0006351
|
transcription, DNA-dependent
|
1.31
|
7.50e-21
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.31
|
9.69e-21
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.29
|
9.76e-21
|
GO:0009889
|
regulation of biosynthetic process
|
1.29
|
1.03e-20
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.30
|
1.15e-20
|
GO:0044267
|
cellular protein metabolic process
|
1.29
|
1.99e-20
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.29
|
1.99e-20
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.32
|
3.29e-20
|
GO:0051252
|
regulation of RNA metabolic process
|
1.31
|
5.53e-20
|
GO:0044249
|
cellular biosynthetic process
|
1.50
|
2.72e-19
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.23
|
2.79e-19
|
GO:0032502
|
developmental process
|
1.43
|
2.90e-19
|
GO:0009893
|
positive regulation of metabolic process
|
1.29
|
8.74e-19
|
GO:0009058
|
biosynthetic process
|
1.37
|
9.38e-19
|
GO:0006996
|
organelle organization
|
1.21
|
2.52e-18
|
GO:0051716
|
cellular response to stimulus
|
1.44
|
3.70e-18
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.25
|
6.47e-18
|
GO:0048856
|
anatomical structure development
|
1.35
|
8.15e-18
|
GO:0016070
|
RNA metabolic process
|
1.23
|
1.04e-17
|
GO:0007275
|
multicellular organismal development
|
1.36
|
1.37e-17
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.35
|
3.07e-17
|
GO:0009059
|
macromolecule biosynthetic process
|
1.25
|
4.46e-17
|
GO:0019538
|
protein metabolic process
|
1.42
|
5.19e-17
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.30
|
7.50e-17
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.48
|
1.67e-16
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.46
|
1.89e-16
|
GO:0009892
|
negative regulation of metabolic process
|
1.32
|
4.13e-16
|
GO:0010467
|
gene expression
|
1.46
|
6.17e-16
|
GO:0032774
|
RNA biosynthetic process
|
1.25
|
1.20e-15
|
GO:0048731
|
system development
|
1.46
|
6.70e-15
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.28
|
1.45e-14
|
GO:0065008
|
regulation of biological quality
|
1.54
|
8.14e-14
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.55
|
9.76e-14
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.34
|
1.42e-13
|
GO:0009653
|
anatomical structure morphogenesis
|
1.46
|
1.69e-13
|
GO:0051128
|
regulation of cellular component organization
|
1.48
|
1.98e-13
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.20
|
2.40e-13
|
GO:0023052
|
signaling
|
1.50
|
2.50e-13
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.52
|
2.60e-13
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
1.52
|
2.94e-13
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.21
|
4.83e-13
|
GO:0007165
|
signal transduction
|
1.42
|
6.60e-13
|
GO:0042127
|
regulation of cell proliferation
|
1.26
|
6.76e-13
|
GO:0042221
|
response to chemical stimulus
|
1.47
|
7.27e-13
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.52
|
1.12e-12
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.68
|
1.71e-12
|
GO:0016568
|
chromatin modification
|
1.49
|
1.96e-12
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.52
|
7.12e-12
|
GO:0010629
|
negative regulation of gene expression
|
1.48
|
1.21e-11
|
GO:0010628
|
positive regulation of gene expression
|
1.42
|
1.93e-11
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.53
|
2.02e-11
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.43
|
2.07e-11
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.32
|
2.42e-11
|
GO:0009966
|
regulation of signal transduction
|
1.26
|
2.61e-11
|
GO:0048869
|
cellular developmental process
|
1.48
|
3.75e-11
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.26
|
4.27e-11
|
GO:0030154
|
cell differentiation
|
1.34
|
5.09e-11
|
GO:0051641
|
cellular localization
|
1.29
|
5.45e-11
|
GO:0023051
|
regulation of signaling
|
1.53
|
9.20e-11
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.36
|
1.03e-10
|
GO:0051246
|
regulation of protein metabolic process
|
1.53
|
1.83e-10
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
1.30
|
2.11e-10
|
GO:0007399
|
nervous system development
|
1.37
|
2.59e-10
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.33
|
2.99e-10
|
GO:0010033
|
response to organic substance
|
1.48
|
4.44e-10
|
GO:0051276
|
chromosome organization
|
1.42
|
5.45e-10
|
GO:0046907
|
intracellular transport
|
1.36
|
6.34e-10
|
GO:0006793
|
phosphorus metabolic process
|
1.36
|
6.34e-10
|
GO:0006796
|
phosphate metabolic process
|
1.42
|
9.82e-10
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.46
|
1.21e-09
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.38
|
1.26e-09
|
GO:0050793
|
regulation of developmental process
|
1.18
|
1.33e-09
|
GO:0051179
|
localization
|
1.38
|
2.63e-09
|
GO:0008219
|
cell death
|
1.53
|
3.06e-09
|
GO:0072358
|
cardiovascular system development
|
1.53
|
3.06e-09
|
GO:0072359
|
circulatory system development
|
1.43
|
3.40e-09
|
GO:0019220
|
regulation of phosphate metabolic process
|
1.43
|
3.40e-09
|
GO:0051174
|
regulation of phosphorus metabolic process
|
1.38
|
3.41e-09
|
GO:0016265
|
death
|
1.85
|
3.76e-09
|
GO:0016569
|
covalent chromatin modification
|
1.40
|
4.35e-09
|
GO:0031399
|
regulation of protein modification process
|
1.30
|
4.37e-09
|
GO:0033036
|
macromolecule localization
|
1.39
|
4.98e-09
|
GO:0033554
|
cellular response to stress
|
1.52
|
7.31e-09
|
GO:0006325
|
chromatin organization
|
1.84
|
8.01e-09
|
GO:0016570
|
histone modification
|
1.24
|
1.79e-08
|
GO:0048583
|
regulation of response to stimulus
|
1.42
|
2.33e-08
|
GO:0042325
|
regulation of phosphorylation
|
1.28
|
3.38e-08
|
GO:0065009
|
regulation of molecular function
|
1.29
|
4.04e-08
|
GO:0051239
|
regulation of multicellular organismal process
|
1.60
|
4.15e-08
|
GO:0032535
|
regulation of cellular component size
|
1.21
|
4.35e-08
|
GO:0006950
|
response to stress
|
1.43
|
4.76e-08
|
GO:0051726
|
regulation of cell cycle
|
1.31
|
8.42e-08
|
GO:0051649
|
establishment of localization in cell
|
1.47
|
8.48e-08
|
GO:0070727
|
cellular macromolecule localization
|
1.23
|
9.30e-08
|
GO:0048513
|
organ development
|
1.61
|
1.02e-07
|
GO:0051130
|
positive regulation of cellular component organization
|
1.34
|
1.35e-07
|
GO:0022008
|
neurogenesis
|
1.32
|
1.38e-07
|
GO:0008104
|
protein localization
|
1.55
|
1.41e-07
|
GO:0044419
|
interspecies interaction between organisms
|
1.46
|
1.47e-07
|
GO:0034613
|
cellular protein localization
|
1.32
|
1.67e-07
|
GO:0010646
|
regulation of cell communication
|
1.46
|
1.81e-07
|
GO:0051338
|
regulation of transferase activity
|
1.38
|
1.85e-07
|
GO:2000026
|
regulation of multicellular organismal development
|
1.30
|
2.09e-07
|
GO:0044248
|
cellular catabolic process
|
1.49
|
2.14e-07
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
1.32
|
2.76e-07
|
GO:0042981
|
regulation of apoptosis
|
1.11
|
2.99e-07
|
GO:0050896
|
response to stimulus
|
1.40
|
3.06e-07
|
GO:0045595
|
regulation of cell differentiation
|
1.60
|
3.15e-07
|
GO:0006366
|
transcription from RNA polymerase II promoter
|
1.61
|
3.63e-07
|
GO:0001944
|
vasculature development
|
1.31
|
4.56e-07
|
GO:0022607
|
cellular component assembly
|
1.63
|
4.61e-07
|
GO:0001568
|
blood vessel development
|
1.53
|
5.17e-07
|
GO:0090066
|
regulation of anatomical structure size
|
1.34
|
5.67e-07
|
GO:0048699
|
generation of neurons
|
1.31
|
6.46e-07
|
GO:0043067
|
regulation of programmed cell death
|
1.40
|
8.11e-07
|
GO:0001932
|
regulation of protein phosphorylation
|
1.40
|
1.08e-06
|
GO:0032989
|
cellular component morphogenesis
|
1.54
|
1.18e-06
|
GO:0018193
|
peptidyl-amino acid modification
|
1.41
|
1.19e-06
|
GO:0000902
|
cell morphogenesis
|
1.34
|
1.89e-06
|
GO:0016310
|
phosphorylation
|
1.37
|
1.99e-06
|
GO:0009790
|
embryo development
|
1.34
|
2.07e-06
|
GO:0044093
|
positive regulation of molecular function
|
1.45
|
2.12e-06
|
GO:0043549
|
regulation of kinase activity
|
1.17
|
2.67e-06
|
GO:0051234
|
establishment of localization
|
1.30
|
2.84e-06
|
GO:0010941
|
regulation of cell death
|
1.32
|
3.07e-06
|
GO:0048468
|
cell development
|
1.44
|
3.16e-06
|
GO:0000904
|
cell morphogenesis involved in differentiation
|
1.36
|
3.56e-06
|
GO:0012501
|
programmed cell death
|
1.30
|
3.56e-06
|
GO:0007049
|
cell cycle
|
1.47
|
3.66e-06
|
GO:0008285
|
negative regulation of cell proliferation
|
1.28
|
3.77e-06
|
GO:0050790
|
regulation of catalytic activity
|
1.22
|
3.77e-06
|
GO:0044281
|
small molecule metabolic process
|
1.65
|
3.79e-06
|
GO:0048011
|
nerve growth factor receptor signaling pathway
|
1.17
|
4.18e-06
|
GO:0006810
|
transport
|
1.46
|
4.21e-06
|
GO:0048667
|
cell morphogenesis involved in neuron differentiation
|
1.27
|
4.90e-06
|
GO:0044085
|
cellular component biogenesis
|
1.25
|
5.15e-06
|
GO:0035556
|
intracellular signal transduction
|
1.38
|
5.51e-06
|
GO:0030030
|
cell projection organization
|
1.48
|
6.07e-06
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.35
|
6.81e-06
|
GO:0006468
|
protein phosphorylation
|
1.42
|
7.30e-06
|
GO:0043065
|
positive regulation of apoptosis
|
1.44
|
8.74e-06
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.43
|
8.98e-06
|
GO:0007010
|
cytoskeleton organization
|
1.59
|
1.01e-05
|
GO:0008361
|
regulation of cell size
|
1.47
|
1.05e-05
|
GO:0009968
|
negative regulation of signal transduction
|
1.41
|
1.41e-05
|
GO:0043068
|
positive regulation of programmed cell death
|
1.39
|
1.44e-05
|
GO:0050878
|
regulation of body fluid levels
|
1.38
|
1.80e-05
|
GO:0006259
|
DNA metabolic process
|
1.34
|
1.90e-05
|
GO:0006915
|
apoptosis
|
1.45
|
2.26e-05
|
GO:0007409
|
axonogenesis
|
1.40
|
2.49e-05
|
GO:0010942
|
positive regulation of cell death
|
1.42
|
2.68e-05
|
GO:0045859
|
regulation of protein kinase activity
|
1.41
|
2.69e-05
|
GO:0032990
|
cell part morphogenesis
|
1.60
|
2.96e-05
|
GO:0051129
|
negative regulation of cellular component organization
|
1.50
|
3.29e-05
|
GO:0070647
|
protein modification by small protein conjugation or removal
|
1.37
|
3.53e-05
|
GO:0009725
|
response to hormone stimulus
|
1.36
|
3.56e-05
|
GO:0071310
|
cellular response to organic substance
|
1.41
|
3.59e-05
|
GO:0048858
|
cell projection morphogenesis
|
1.43
|
4.07e-05
|
GO:0048812
|
neuron projection morphogenesis
|
1.21
|
4.11e-05
|
GO:0007166
|
cell surface receptor linked signaling pathway
|
1.38
|
4.35e-05
|
GO:0055086
|
nucleobase, nucleoside and nucleotide metabolic process
|
1.43
|
4.71e-05
|
GO:0010648
|
negative regulation of cell communication
|
1.40
|
4.78e-05
|
GO:0007599
|
hemostasis
|
1.34
|
4.82e-05
|
GO:0043085
|
positive regulation of catalytic activity
|
1.35
|
5.23e-05
|
GO:0009719
|
response to endogenous stimulus
|
1.43
|
6.82e-05
|
GO:0023057
|
negative regulation of signaling
|
1.40
|
7.85e-05
|
GO:0007596
|
blood coagulation
|
1.40
|
7.85e-05
|
GO:0050817
|
coagulation
|
1.45
|
9.15e-05
|
GO:0006886
|
intracellular protein transport
|
1.28
|
9.53e-05
|
GO:0032879
|
regulation of localization
|
1.30
|
9.59e-05
|
GO:0009888
|
tissue development
|
1.52
|
1.06e-04
|
GO:0071900
|
regulation of protein serine/threonine kinase activity
|
1.40
|
1.11e-04
|
GO:0031175
|
neuron projection development
|
1.43
|
1.12e-04
|
GO:0040008
|
regulation of growth
|
1.23
|
1.21e-04
|
GO:0009056
|
catabolic process
|
1.38
|
1.76e-04
|
GO:0006753
|
nucleoside phosphate metabolic process
|
1.38
|
1.76e-04
|
GO:0009117
|
nucleotide metabolic process
|
1.48
|
1.79e-04
|
GO:0033043
|
regulation of organelle organization
|
1.33
|
1.85e-04
|
GO:0030182
|
neuron differentiation
|
1.50
|
2.00e-04
|
GO:0002520
|
immune system development
|
1.35
|
2.00e-04
|
GO:0042060
|
wound healing
|
1.51
|
2.08e-04
|
GO:0051270
|
regulation of cellular component movement
|
1.86
|
2.17e-04
|
GO:0040029
|
regulation of gene expression, epigenetic
|
1.38
|
2.56e-04
|
GO:0006974
|
response to DNA damage stimulus
|
1.38
|
2.67e-04
|
GO:0048585
|
negative regulation of response to stimulus
|
1.42
|
2.69e-04
|
GO:0051247
|
positive regulation of protein metabolic process
|
1.60
|
3.14e-04
|
GO:0043405
|
regulation of MAP kinase activity
|
1.47
|
3.26e-04
|
GO:0007411
|
axon guidance
|
1.38
|
3.33e-04
|
GO:0070271
|
protein complex biogenesis
|
1.31
|
3.56e-04
|
GO:0016192
|
vesicle-mediated transport
|
1.48
|
4.01e-04
|
GO:0032870
|
cellular response to hormone stimulus
|
1.46
|
4.16e-04
|
GO:0071495
|
cellular response to endogenous stimulus
|
1.51
|
4.66e-04
|
GO:0048534
|
hemopoietic or lymphoid organ development
|
1.48
|
4.66e-04
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
1.38
|
5.35e-04
|
GO:0006461
|
protein complex assembly
|
1.49
|
5.37e-04
|
GO:0030029
|
actin filament-based process
|
1.35
|
5.85e-04
|
GO:0048666
|
neuron development
|
1.76
|
6.05e-04
|
GO:0007265
|
Ras protein signal transduction
|
1.47
|
6.27e-04
|
GO:0060284
|
regulation of cell development
|
1.43
|
6.31e-04
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
1.53
|
6.34e-04
|
GO:0030097
|
hemopoiesis
|
1.52
|
8.18e-04
|
GO:0030036
|
actin cytoskeleton organization
|
1.27
|
8.39e-04
|
GO:0045184
|
establishment of protein localization
|
1.43
|
8.45e-04
|
GO:0043009
|
chordate embryonic development
|
1.10
|
8.68e-04
|
GO:0032501
|
multicellular organismal process
|
1.33
|
9.03e-04
|
GO:0009057
|
macromolecule catabolic process
|
1.28
|
1.03e-03
|
GO:0022402
|
cell cycle process
|
1.59
|
1.11e-03
|
GO:0048732
|
gland development
|
1.50
|
1.17e-03
|
GO:0030334
|
regulation of cell migration
|
1.39
|
1.26e-03
|
GO:0032583
|
regulation of gene-specific transcription
|
1.50
|
1.31e-03
|
GO:2000145
|
regulation of cell motility
|
1.35
|
1.45e-03
|
GO:0008284
|
positive regulation of cell proliferation
|
1.35
|
1.46e-03
|
GO:0044265
|
cellular macromolecule catabolic process
|
1.48
|
1.48e-03
|
GO:0032446
|
protein modification by small protein conjugation
|
1.48
|
1.73e-03
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
1.27
|
1.90e-03
|
GO:0015031
|
protein transport
|
1.74
|
1.91e-03
|
GO:0032386
|
regulation of intracellular transport
|
1.38
|
1.91e-03
|
GO:0072521
|
purine-containing compound metabolic process
|
1.25
|
2.02e-03
|
GO:0009605
|
response to external stimulus
|
1.32
|
2.08e-03
|
GO:0005975
|
carbohydrate metabolic process
|
1.40
|
2.17e-03
|
GO:0032270
|
positive regulation of cellular protein metabolic process
|
1.79
|
2.22e-03
|
GO:0046822
|
regulation of nucleocytoplasmic transport
|
1.26
|
2.58e-03
|
GO:0009611
|
response to wounding
|
1.65
|
3.33e-03
|
GO:0050678
|
regulation of epithelial cell proliferation
|
1.41
|
3.36e-03
|
GO:0006917
|
induction of apoptosis
|
1.64
|
3.49e-03
|
GO:0007568
|
aging
|
1.41
|
3.60e-03
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
1.37
|
3.76e-03
|
GO:0051094
|
positive regulation of developmental process
|
1.41
|
3.88e-03
|
GO:0010564
|
regulation of cell cycle process
|
1.39
|
4.04e-03
|
GO:0010627
|
regulation of intracellular protein kinase cascade
|
1.91
|
4.06e-03
|
GO:0071901
|
negative regulation of protein serine/threonine kinase activity
|
1.21
|
4.09e-03
|
GO:0002376
|
immune system process
|
1.86
|
4.14e-03
|
GO:0018205
|
peptidyl-lysine modification
|
1.41
|
4.17e-03
|
GO:0012502
|
induction of programmed cell death
|
1.67
|
4.30e-03
|
GO:0006470
|
protein dephosphorylation
|
1.67
|
4.30e-03
|
GO:0051348
|
negative regulation of transferase activity
|
1.31
|
4.51e-03
|
GO:0009887
|
organ morphogenesis
|
1.37
|
4.66e-03
|
GO:0007243
|
intracellular protein kinase cascade
|
1.37
|
4.66e-03
|
GO:0023014
|
signal transduction via phosphorylation event
|
1.26
|
4.82e-03
|
GO:0040011
|
locomotion
|
1.52
|
5.39e-03
|
GO:0048514
|
blood vessel morphogenesis
|
1.24
|
5.87e-03
|
GO:0070887
|
cellular response to chemical stimulus
|
1.44
|
6.06e-03
|
GO:0042493
|
response to drug
|
1.36
|
6.27e-03
|
GO:0044262
|
cellular carbohydrate metabolic process
|
1.36
|
6.59e-03
|
GO:0008283
|
cell proliferation
|
1.29
|
7.39e-03
|
GO:0046483
|
heterocycle metabolic process
|
1.42
|
7.39e-03
|
GO:0051098
|
regulation of binding
|
1.72
|
7.91e-03
|
GO:2000241
|
regulation of reproductive process
|
1.41
|
8.54e-03
|
GO:0051093
|
negative regulation of developmental process
|
1.70
|
8.65e-03
|
GO:0060541
|
respiratory system development
|
1.27
|
9.51e-03
|
GO:0071844
|
cellular component assembly at cellular level
|
2.01
|
9.65e-03
|
GO:0043407
|
negative regulation of MAP kinase activity
|
1.40
|
1.13e-02
|
GO:0043434
|
response to peptide hormone stimulus
|
1.44
|
1.17e-02
|
GO:0035295
|
tube development
|
1.52
|
1.20e-02
|
GO:0044087
|
regulation of cellular component biogenesis
|
1.94
|
1.27e-02
|
GO:0006475
|
internal protein amino acid acetylation
|
1.87
|
1.32e-02
|
GO:0048638
|
regulation of developmental growth
|
1.61
|
1.34e-02
|
GO:0016311
|
dephosphorylation
|
2.39
|
1.44e-02
|
GO:2000242
|
negative regulation of reproductive process
|
1.43
|
1.49e-02
|
GO:0040012
|
regulation of locomotion
|
1.88
|
1.50e-02
|
GO:0006473
|
protein acetylation
|
1.40
|
1.50e-02
|
GO:0009259
|
ribonucleotide metabolic process
|
1.54
|
1.52e-02
|
GO:0051169
|
nuclear transport
|
1.45
|
1.77e-02
|
GO:0045596
|
negative regulation of cell differentiation
|
1.54
|
1.78e-02
|
GO:0006913
|
nucleocytoplasmic transport
|
1.44
|
1.81e-02
|
GO:0007346
|
regulation of mitotic cell cycle
|
1.44
|
2.06e-02
|
GO:0016567
|
protein ubiquitination
|
1.32
|
2.06e-02
|
GO:0009967
|
positive regulation of signal transduction
|
1.48
|
2.26e-02
|
GO:0071375
|
cellular response to peptide hormone stimulus
|
1.76
|
2.34e-02
|
GO:0002224
|
toll-like receptor signaling pathway
|
1.91
|
2.48e-02
|
GO:0018394
|
peptidyl-lysine acetylation
|
1.85
|
2.49e-02
|
GO:0045793
|
positive regulation of cell size
|
1.42
|
2.50e-02
|
GO:0051345
|
positive regulation of hydrolase activity
|
1.27
|
2.60e-02
|
GO:0022403
|
cell cycle phase
|
1.64
|
2.78e-02
|
GO:0033673
|
negative regulation of kinase activity
|
1.29
|
2.90e-02
|
GO:0000278
|
mitotic cell cycle
|
1.34
|
2.98e-02
|
GO:0060341
|
regulation of cellular localization
|
1.31
|
3.30e-02
|
GO:0080134
|
regulation of response to stress
|
1.62
|
3.36e-02
|
GO:0010769
|
regulation of cell morphogenesis involved in differentiation
|
1.61
|
3.43e-02
|
GO:0034329
|
cell junction assembly
|
1.30
|
3.47e-02
|
GO:0006928
|
cellular component movement
|
1.87
|
3.71e-02
|
GO:0034138
|
toll-like receptor 3 signaling pathway
|
2.26
|
3.77e-02
|
GO:0019048
|
virus-host interaction
|
1.37
|
3.82e-02
|
GO:0006281
|
DNA repair
|
1.42
|
3.83e-02
|
GO:0051101
|
regulation of DNA binding
|
1.40
|
3.85e-02
|
GO:0009199
|
ribonucleoside triphosphate metabolic process
|
1.62
|
3.93e-02
|
GO:0010975
|
regulation of neuron projection development
|
1.44
|
3.95e-02
|
GO:0050767
|
regulation of neurogenesis
|
1.35
|
3.98e-02
|
GO:0006163
|
purine nucleotide metabolic process
|
1.82
|
4.06e-02
|
GO:0010563
|
negative regulation of phosphorus metabolic process
|
1.82
|
4.06e-02
|
GO:0045936
|
negative regulation of phosphate metabolic process
|
1.57
|
4.10e-02
|
GO:0001655
|
urogenital system development
|
1.39
|
4.30e-02
|
GO:0009150
|
purine ribonucleotide metabolic process
|
1.64
|
4.45e-02
|
GO:0006469
|
negative regulation of protein kinase activity
|
1.48
|
4.58e-02
|
GO:0001701
|
in utero embryonic development
|
1.61
|
4.71e-02
|
GO:0022604
|
regulation of cell morphogenesis
|
1.67
|
4.71e-02
|
GO:0045927
|
positive regulation of growth
|
1.39
|
4.71e-02
|
GO:0009141
|
nucleoside triphosphate metabolic process
|
1.89
|
4.79e-02
|
GO:0018393
|
internal peptidyl-lysine acetylation
|
1.57
|
4.80e-02
|
GO:0051052
|
regulation of DNA metabolic process
|